文献速递肾小球疾病

IgA肾病中单肾单位eGFR与肾功能下降的关系

Single-nephron eGFR and kidney function decline in IgA nephropathy.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

该观察性队列纳入187例经活检确诊的IgA肾病患者,基于CT和活检估算单肾单位eGFR(总eGFR除以肾单位数)。中位随访3.1年,57例发生肾功能下降;高单肾单位eGFR组肾功能下降风险显著升高,多变量HR达5.30。提示单肾单位eGFR可作为早期风险分层工具。

要点

  • 高单肾单位eGFR是IgA肾病肾功能下降的独立危险因素。
  • 与低组相比,中组和高组多变量HR分别为2.50和5.30。
  • 仅用eGFR cutoff定义高滤过可能导致误分类。

核心结论

  • 高单肾单位eGFR被确定为IgA肾病患者肾功能下降的危险因素,支持其作为早期风险分层工具的潜力。
  • 仅用eGFR cutoff定义高滤过可能因无法区分有无高滤过患者而导致误分类。

研究设计与样本

  • 观察性队列研究,纳入187例住院期间接受CT和活检的活检确诊IgA肾病患者。
  • 单肾单位eGFR通过总eGFR除以肾单位数估算,肾单位数由皮质体积和肾小球密度得出。
  • 主要复合结局为肾功能下降:持续年eGFR下降≥5 mL/min/1.73 m2、eGFR较基线下降≥40%或终末期肾病。

主要发现

  • 187例参与者中45%为女性,平均年龄38±11岁;中位随访3.1年,57例发生肾功能下降。
  • Kaplan-Meier分析显示高单肾单位eGFR组肾脏生存率显著低于低组和中组(log-rank P < .001)。
  • 与低单肾单位eGFR组相比,中组多变量HR为2.50(95%CI 1.10-5.67;P = .03),高组为5.30(95%CI 2.44-11.54;P < .001)。

临床怎么用

  • 在IgA肾病患者中可考虑估算单肾单位eGFR以辅助早期风险分层。
  • 评估高滤过时不应仅依赖eGFR cutoff,需结合单肾单位eGFR避免误分类。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: During the progression of immunoglobulin A nephropathy (IgAN), residual nephrons compensate for nephron loss by increasing single-nephron estimated glomerular filtration rate (eGFR). This adaptive hyperfiltration may accelerate the decline in kidney function. However, due to measurement challenges, the prognostic value of single-nephron eGFR remains unclear. This study investigates its impact on kidney function decline in patients with IgAN. METHODS: This observational cohort study included 187 biopsy-confirmed IgAN patients who had undergone computed tomography and biopsy during their hospitalization. Single-nephron eGFR was estimated by dividing total eGFR by nephron number, the latter of which was derived from the cortical volume and glomerular density. The primary composite outcome was kidney function decline, defined as a sustained annual eGFR decrease of ≥5 mL/min/1.73 m2, a ≥40% reduction in eGFR from baseline or end-stage renal disease. Cox proportional hazards models were fit to estimate associations between single-nephron eGFR and kidney function decline. RESULTS: Among the 187 participants (45% women, mean age 38 ± 11 years), 57 experienced a decline in kidney function over a median follow-up period of 3.1 years. Participants were divided into three groups based on their single-nephron eGFR. Kaplan-Meier analysis demonstrated significantly reduced kidney survival in the high single-nephron eGFR group compared with the low and middle groups (log-rank P < .001). Compared with the low single-nephron eGFR group, multivariable hazard ratios for kidney function decline were 2.50 (95% confidence interval 1.10-5.67; P = .03) for the middle group and 5.30 (2.44-11.54; P < .001) for the high group. CONCLUSIONS: A higher single-nephron eGFR is identified as a risk factor for kidney function decline in patients with IgAN, which supports its potential as an early risk-stratification tool. Moreover, using eGFR cutoffs alone to define hyperfiltration may lead to misclassification due to its inability to distinguish patients with hyperfiltration from those without.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Yang C, Liang S, Duan ZY, et al. Single-nephron eGFR and kidney function decline in IgA nephropathy. Nephrol Dial Transplant. 2026. PMID: 41627293. doi:10.1093/ndt/gfag019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。